Neridronate Sodium
Tier C — Watch / tradeNeridronate Sodium
Targets：Bone resorption factor
Indications (approved)：成骨不全, Paget's disease
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| NERI-001 | 60-32-2 | 6-aminohexanoic acid |
Frequently asked questions
What are the approved indications of Neridronate Sodium?
Approved indications include: 成骨不全, Paget's disease.
When does the Neridronate Sodium patent expire?
No public expiry year is available for Neridronate Sodium yet; this page updates once verified.
How many synthesis routes are recorded for Neridronate Sodium?
1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Neridronate Sodium intermediates?
All intermediates in Neridronate Sodium routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Neridronate Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29